OneSource optimistic on weight-loss drug prospects, raises FY28 revenue guidance to over $500 mn

New Delhi, Nov. 13 -- Backed by strong demand across its drug-device and biologics businesses, OneSource Speciality Pharma has raised its FY28 revenue guidance from $400 million to over $500 million, ... Read More

Biocon banks on weight-loss drugs, raises stake in biosimilar arm

Mumbai, Nov. 12 -- Weight-loss and diabetes drugs such as semaglutide and liraglutide are expected to drive near-term growth in Biocon Ltd's generics business, chief executive and managing director Si... Read More

Novo Nordisk slashes weight-loss drug Wegovy's prices as competition heats up

New Delhi, Nov. 11 -- Danish drugmaker Novo Nordisk on Tuesday announced it was slashing the price of its weight-loss drug Wegovy in India. The company said the monthly price of its once-a-week inject... Read More

Mint Explainer | Why the drug regulator is cracking down on small and medium-sized pharma companies

New Delhi, Nov. 11 -- India's top drug regulator has ordered a nationwide crackdown on pharmaceutical manufacturers to enforce stricter quality standards. India's Drugs Controller General of India (DC... Read More

Novo Nordisk bets on Emcure to win India's weight-loss drug war

New Delhi, Nov. 10 -- Danish drugmaker Novo Nordisk on Monday announced an exclusive partnership with Pune-based Emcure Pharmaceuticals to widely distribute its weight-loss therapy semaglutide, as com... Read More

Divi's Labs Q2 net profit soars 35%, forex gain boosts

New Delhi, Nov. 7 -- Divi's Laboratories Ltd on Friday beat Street estimates to report a robust double-digit revenue and profit growth for July-September, the second quarter of this fiscal year. The ... Read More

Mounjaro gains weight, tops India's drug charts with Rs.100 crore sales in October

New Delhi, Nov. 7 -- Sales of Eli Lilly's blockbuster weight-loss drug Mounjaro have soared in India, making it the top-selling brand in October, just six months after its launch in the world's most p... Read More

Specialty care offsets seasonal dip, lifts Apollo Hospitals' Q2 profit 26%

New Delhi, Nov. 6 -- Apollo Hospitals Enterprise Ltd's September-quarter financial performance beat Street expectations, as gains in its specialty care like cardiac, oncology, neurosciences, gastroent... Read More

Zydus Lifesciences beats expectations, plans to raise Rs.5,000 crore

Mumbai, Nov. 6 -- Zydus Lifesciences Ltd reported double-digit revenue and profit growth on Thursday, beating expectations for the September quarter. The Ahmedabad-based drugmaker's consolidated reve... Read More

Piramal Pharma bets on US biopharma funding uptick to lift growth

MUMBAI, Nov. 6 -- Nandini Piramal, chairperson of Piramal Pharma, speaking to reporters on Thursday, said a rebound in US biopharma funding could boost future orders, even as the company on Wednesday ... Read More

• «
• 1
• 2
• 3
• 4
• »